Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder

Journal of Affective Disorders

Volumn 147, Issue 1-3, 2013, Pages 144-149

  Gałecki, Piotr ^a,b   Orzechowska, Agata ^a,b   Berent, Dominika ^a,b   Talarowska, Monika ^a,b   Bobińska, Kinga ^a,b   Gałecka, Elzbieta ^a   Lewiński, Andrzej ^a,b   Maes, Michael ^c   Szemraj, Janusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c Piyavate Hospital   (Thailand)

Author keywords

KDR expression; KDR gene; Recurrent depressive disorder

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; VASCULOTROPIN RECEPTOR 2;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECURRENCE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84875369347     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.10.025     Document Type: Article

References (42)

1. S.J. An, Z.H. Chen, Q.-X. Lin, J. Su, H.-J. Chen, J.-Y. Lin, and Y.-L. Wu The-271 G/A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer BMC Cancer 9 144 2009 1 6
2. A. Brockington, B. Wokke, H. Nixon, J. Hartley, and P.J. Shaw Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis BMC Medical Genetics 8 2007 23
3. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Analytical Biochemistry 162 1987 156 159
4. T. Covic, S.R. Cumming, J.F. Pallant, N. Manolios, P. Emery, P.G. Conaghan, and A. Tennant Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS) BMC Psychiatry 24 2012 6
5. Y. Dwivedi Brain-derived neurotrophic factor in suicide pathophysiology Y. Dwivedi, The Neurobiological Basis of Suicide. Boca Raton (FL) 2012 CRC Press
6. X.H. Fan, H. Wang, L.G. Gao, K. Sun, X.L. Zhou, and R.T. Hui The association of an adenine insertion variant in the 5'UTR of the endothelin-1 gene with hypertension and orthostatic hypotension Archives of Medical Science 8 2 2012 219 226 9
7. C. Feistritzer, N.C. Kaneider, D.H. Sturn, B.A. Mosheimer, C.M. Kähler, and C.J. Wiedermann Expression and function of the vascular endothelial growth factor receptor FLT-1 in human eosinophils American Journal of Respiratory Cell and Molecular Biology 30 2004 729 735
8. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nature Medicine 1 1995 27 31
9. N.M. Fournier, and R.S. Duman Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression Behavioural Brain Research 227 2 2012 440 449
10. N.M. Fournier, B. Lee, M. Banasr, M. Elsayed, and R.S. Duman Vascular endothelial growth factor regulates adult hippocampal cell proliferation through MEK/ERK- and PI3K/Akt-dependent signaling Neuropharmacology. 2012 May 2012 10
11. P. Gałecki, A. Florkowski, M. Bieńkiewicz, and J. Szemraj Functional polymorphism of cyclooxygenase-2 gene (G-765C) in depressive patients Neuropsychobiology 62 2010 116 120
12. P. Gałecki, E. Gałecka, M. Maes, M. Chamielec, A. Orzechowska, K. Bobińska, A. Lewiński, and J. Szemraj The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder Journal of Affective Disorders 138 2012 360 366
13. P. Gałecki, A. Florkowski, K. Bobińska, J. Śmigielski, M. Bieńkiewicz, and J. Szemraj Functional polymorphism of the myeloperoxidase gene (G-463 A) in depressive patients Acta Neuropsychiatrica 22 2010 218 222
14. L. Ibrahim, W. Duncan, D.A. Luckenbaugh, P. Yuan, R. Machado-Vieira, and C.A. Zarate Jr. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study Brain Research Bulletin 86 2011 129 133
15. J. Iga, S. Ueno, K. Yamauchi, S. Numata, S. Tayoshi-Shibuya, S. Kinouchi, M. Nakataki, H. Song, K. Hokoishi, H. Tanabe, A. Sano, and T. Ohmori Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 2007 658 663
16. J. Isung, F. Mobarrez, P. Nordström, M. Asberg, and J. Jokinen Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide World Journal of Biological Psychiatry 13 2012 468 473
17. K.G. Kahl, S. Bens, K. Ziegler, S. Rudolf, A. Kordon, L. Dibbelt, and U. Schweiger Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder Psychoneuroendocrinology 2009 34 2009 353 357
18. D. Kajdaniuk, B. Marek, W. Fołtyn, and B. Kos-Kudła Vascular endothelial growth factor (VEGF) in endocrinology and oncology Endokrynologia Polska 62 2011 14 22
19. W. Katon, E.H. Lin, and K. Kroenke The association of depression and anxiety with medical symptom burden in patients with chronic medical illness General Hospital Psychiatry 29 2007 147 155
20. W.J. Katon Epidemiology and treatment of depression in patients with chronic medical illness Dialogues in Clinical Neuroscience 13 2011 7 23
21. D. Lambrechts, E. Storkebaum, M. Morimoto, J. Del-Favero, F. Desmet, S.L. Marklund, S. Wyns, V. Thijs, J. Andersson, I. van Marion, A. Al-Chalabi, S. Bornes, R. Musson, V. Hansen, L. Beckman, R. Adolfsson, H.S. Pall, H. Prats, S. Vermeire, P. Rutgeerts, S. Katayama, T. Awata, N. Leigh, L. Lang-Lazdunski, M. Dewerchin, C. Shaw, L. Moons, R. Vlietinck, K.E. Morrison, W. Robberecht, C. Van Broeckhoven, D. Collen, P.M. Andersen, and P. Carmeliet VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nature Genetics 34 2003 383 394
22. B.H. Lee, and Y.K. Kim Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders Journal of Affective Disorders 136 2012 181 184
23. K.Y. Lee, K.S. Lee, S.J. Park, S.R. Kim, K.H. Min, Y.H. Choe, and Y.C. Lee Clinical significance of plasma and serum vascular endothelial growth factor in asthma Journal of Asthma 45 2008 735 739
24. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method Methods 25 2001 402 408
25. M. Maes, B. Leonard, A. Fernandez, M. Kubera, G. Nowak, R. Veerhuis, A. Gardner, P. Ruckoanich, M. Geffard, C. Altamura, P. Gałecki, and M. Berk (Neuro) inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 2011 659 663
26. M. Maes Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression Progress in Neuro- Psychopharmacology & Biological Psychiatry 29 35 2011 664 675
27. D. Mehta, A. Menke, and E.B. Binder Gene expression studies in major depression Current Psychiatry Reports 12 2010 135 144
28. M.M. Nowacka, and E. Obuchowicz Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action Neuropeptides 46 2012 1 10
29. S.H. Oh, K.T. Min, Y.J. Jeon, M.H. Kim, J.S. Moon, H.S. Kim, W.C. Kim, O.J. Kim, E.K. Park, and N.K. Kim Association between kinase insert domain-containing receptor gene polymorphism and haplotypes and ischemic stroke Journal of the American College of Cardiology 50 8 2007 760 767
30. B. Oosthuyse, L. Moons, E. Storkebaum, H. Beck, D. Nuyens, K. Brusselmans, J. Van Dorpe, P. Hellings, M. Gorselink, S. Heymans, G. Theilmeier, M. Dewerchin, V. Laudenbach, P. Vermylen, H. Raat, T. Acker, V. Vleminckx, L. Van Den Bosch, N. Cashman, H. Fujisawa, M.R. Drost, R. Sciot, F. Bruyninckx, D.J. Hicklin, C. Ince, P. Gressens, F. Lupu, K.H. Plate, W. Robberecht, J.M. Herbert, D. Collen, and P. Carmeliet Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration Nature Genetics 28 2001 131 138
31. H.W. Park, J.E. Lee, E.S. Shin, J.Y. Lee, J.W. Bahn, H.B. Oh, S.Y. Oh, S.H. Cho, H.B. Moon, K.U. Min, J.A. Elias, Y.Y. Kim, and Y.K. Kim Association between genetic variations of vascular endothelial growth factor receptor 2 and atopy in the Korean population Journal of Allergy and Clinical Immunology 117 2006 774 779
32. F. Shalaby, J. Rossant, T.P. Yamaguchi, M. Gertsenstein, X.F. Wu, M.L. Breitman, and A.C. Schuh Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice Nature 376 1995 62 66
33. M. Sondell, G. Lundborg, and M. Kanje Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system Journal of Neuroscience 19 1999 5731 5740
34. M. Sondell, F. Sundler, and M. Kanje Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor European Journal of Neuroscience 12 2000 4243 4254
35. H. Takahashi, and M. Shibuya The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions Clinical Science (Lond) 109 2005 227 241
36. H. Trzcińska, G. Przybylski, B. Kozłowski, and S. Derdowski Analysis of the relation between level of asthma control and depression and anxiety Medical Science Monitor 18 2012 190 194
37. M. Viikki, S. Anttila, O. Kampman, A. Illi, M. Huuhka, E. Setälä-Soikkeli, N. Mononen, T. Lehtimäki, and E. Leinonen Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression Neuroscience Letters 477 2010 105 108
38. Y. Wang, Y. Zheng, W. Zhang, H. Yu, K. Lou, Y. Zhang, Q. Qin, B. Zhao, Y. Yang, and R. Hui Polymorphisms of KDR gene are associated with coronary heart disease Journal of the American College of Cardiology 50 2007 760 767
39. J.L. Warner-Schmidt, and R.S. Duman VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants Proceedings of the National academy of Sciences of the United States of America 104 2007 4647 4652
40. J. Winer, C.K. Jung, I. Shackel, and P.M. Williams Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro Analytical Biochemistry 270 1999 41 49
41. World Health Organization, 1992. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Description and Diagnostic Guidelines.
42. J.C. Wu, and W.E. Bunney The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis The American Journal of Psychiatry 147 1990 14 21